Exclusive Interviews

In this Exclusive Interview, Dr. Espeland discusses the LOOK AHEAD study and its findings, including the impact of lifestyle interventions on healthcare costs, and why exercise and weight loss can reduce cognitive decline, but also increase risk of hypoglycemia.

Dr. Mark Espeland discusses the background of the LOOK AHEAD study, which examines the effects of lifestyle interventions on adults with diabetes.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the LOOK AHEAD study's major findings, including the effectiveness of lifestyle interventions in reducing healthcare costs.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the reasons why exercise and weight loss can improve cognitive function.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the ten-year time period of the LOOK AHEAD study, and what it revealed about the benefit of long-term lifestyle interventions on cognitive health. Dr. Mark Espeland, PhD is the founding …

Dr. Davidson discusses new diabetes drugs and their impact on patient health, including DKA; new combination drugs; and the expensive side effects of sulfonylureas.

In this Exclusive Interview, Dr. Davidson discusses his thoughts on new drugs and their impact on patient health, such as DKA.

Dr. Bruce Bode, MD, FACE, shares his knowledge on the artificial pancreas and diabetes pumps. Dr. Bode is a professor of medicine at Emory University School of Medicine in Atlanta, GA. He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing.

Dr. Bruce Bode discusses the artificial pancreas, advances in continuous glucose monitoring, and insulin pumps.

Dr. Bruce Bode talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the trial and use of the artificial pancreas.